Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339,200,672
-
Total 13F shares
-
151,142,281
-
Share change
-
+3,306,585
-
Total reported value
-
$1,502,010,648
-
Put/Call ratio
-
142%
-
Price per share
-
$9.94
-
Number of holders
-
95
-
Value change
-
+$33,771,301
-
Number of buys
-
51
-
Number of sells
-
36
Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q3 2021
As of 30 Sep 2021,
Nuvation Bio Inc. - Common Stock (NUVB) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
151,142,281 shares.
The largest 10 holders included
FMR LLC, Omega Fund Management, LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, BAUPOST GROUP LLC/MA, Avidity Partners Management LP, CITADEL ADVISORS LLC, BlackRock Inc., Redmile Group, LLC, and BOXER CAPITAL, LLC.
This page lists
95
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.